Your session is about to expire
← Back to Search
Viscosupplementation
Durolane SJ for Osteoarthritis
Phase 4
Waitlist Available
Led By Alistair Younger, MD
Research Sponsored by Bioventus LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 26 weeks
Awards & highlights
Study Summary
26 week open label study of treatment with Durolane for OA pain of the ankle
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 26 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 26 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
AOS pain subscale score
Trial Design
1Treatment groups
Experimental Treatment
Group I: Durolane SJExperimental Treatment1 Intervention
Durolane SJ intra-articular injection; device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Durolane SJ
2013
N/A
~40
Find a Location
Who is running the clinical trial?
Bioventus LLCLead Sponsor
16 Previous Clinical Trials
15,211 Total Patients Enrolled
10 Trials studying Osteoarthritis
1,698 Patients Enrolled for Osteoarthritis
Alistair Younger, MDPrincipal InvestigatorSt. Pauls Hospital
1 Previous Clinical Trials
100 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger